Eyebright Medical Technology (Beijing) Co., Ltd. (688050.SS) SHH

Currency In CNY

AD

Valuation

Market Cap11.67B
Enterprise Value11.41B
P/E Ratio34.84
PEG Ratio-0.83
Price/Sales Ratio4.97
Price/Book Ratio2.8
Enterprise/Revenue5.33
Enterprise/EBITDA21.86

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.14
Operating Margin0.16
AD

Management Effectiveness

Return On Assets0.05
Return On Equity0.08

Income Statement

Revenue1.48B
Revenue/Share8.43
Gross Profit1.48B
EBITDA469.33M
Net Income268.17M
Diluted EPS1.4

Balance Sheet

Total Cash727.33M
Total Cash/Share3.77
Total Debt1.2B
Total Debt/Equity0.42
Current Ratio3.24
Book Value Per Share16.29

Price History

52-Week Change-39.73
52-Week High71.34
52-Week Low35.23
Moving Average 50 Days39.51
Moving Average 200 Days47.19

Statistics

Average Volume2.84M
Shares Outstanding193.44M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.32
Trailing Annual Dividend Yield0.77
Payout Ratio0.05
Last Split Factor9:5
Last Split DateJune 05, 2024
AD